| Citation: |
ZHANG Qian, XU Zhihong. Small-Cell Neuroendocrine Carcinoma of Gallbladder Complicated with Intestinal Obstruction: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2024, 51(7): 613-616. DOI: 10.3971/j.issn.1000-8578.2024.23.1381
|
Competing interests: The authors declare that they have no competing interests.
| [1] |
Wang P, Chen J, Jiang Y, et al. Neuroendocrine neoplasms of the gallbladder: a clinicopathological analysis of 13 patients and a review of the literature[J]. Gastroenterol Res Pract, 2021, 2021: 5592525.
|
| [2] |
Do MY, Jang SI, Kang HP, et al. Comparison of the clinical features and outcomes of gallbladder neuroendocrine carcinoma with those of adenocarcinoma: a propensity scorematched analysis[J]. Cancers (Basel), 2021, 13(18): 4713. doi: 10.3390/cancers13184713
|
| [3] |
Kumar K, Tariq H, Ahmed R, et al. Small-cell type, poorly differentiated neuroendocrine carcinoma of the gallbladder: a case report and review of the literature[J]. Case Rep Oncol Med, 2019, 2019: 8968034.
|
| [4] |
Singh R, Balasubramanian I, Zhang L, et al. Metaplastic Paneth cells in extra-intestinal mucosal niche indicate a link to microbiome and inflammation[J]. Front Physiol, 2020, 11: 280. doi: 10.3389/fphys.2020.00280
|
| [5] |
Shi CJ, Tian R, Wang M, et al. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma[J]. Cancer Biol Ther, 2010, 10(11): 1182-1190. doi: 10.4161/cbt.10.11.13664
|
| [6] |
Park JH, Hong JY, Han KD, et al. Light-to-Moderate Alcohol Consumption Increases the Risk of Biliary Tract Cancer in Prediabetes and Diabetes, but Not in Normoglycemic Status: A Nationwide Cohort Study[J]. J Clin Oncol, 2022, 40(31): 3623-3632. doi: 10.1200/JCO.22.00145
|
| [7] |
郑强, 赵斌, 刘旭东, 等. 胆囊小细胞型神经内分泌癌并发副肿瘤性低钠血症1例报告[J]. 中国微创外科杂志, 2021, 21(10): 954-957. [Zheng Q, Zhao B, Liu XD, et al. Small-cell neuroendocrine carcinoma of gallbladder complicated by paraneoplastic hyponatremia: a case report[J]. Zhongguo Wei Chuang Wai Ke Za Zhi, 2021, 21(10): 954-957.]
Zheng Q, Zhao B, Liu XD, et al. Small-cell neuroendocrine carcinoma of gallbladder complicated by paraneoplastic hyponatremia: a case report[J]. Zhongguo Wei Chuang Wai Ke Za Zhi, 2021, 21(10): 954-957.
|
| [8] |
Adachi T, Haraguchi M, Irie J, et al. Gallbladder small-cell carcinoma: a case report and literature review[J]. Surg Case Rep, 2016, 2(1): 71. doi: 10.1186/s40792-016-0200-3
|
| [9] |
周东奎, 鲁明骞, 林雅欣, 等. 胆囊小细胞癌伴肝脏和腹膜后淋巴结转移1例报告及文献复习[J]. 吉林大学学报(医学版), 2021, 47(3): 747-752. [Zhou DK, Lu MQ, Lin YX, et al. Small-cell carcinoma of gallbladder with liver and retroperitoneal lymph node metastasis: A case report and literature review[J]. Jilin Da Xue Xue Bao(Yi Xue Ban), 2021, 47(3): 747-752.]
Zhou DK, Lu MQ, Lin YX, et al. Small-cell carcinoma of gallbladder with liver and retroperitoneal lymph node metastasis: A case report and literature review[J]. Jilin Da Xue Xue Bao(Yi Xue Ban), 2021, 47(3): 747-752.
|
| [10] |
Inoue D, Ozaka M, Muramatsu Y, et al. Neuroendocrine gallbladder cancer treated with cisplatin plus irinotecan-a case report[J]. Gan To Kagaku Ryoho, 2014, 41(6): 765-767.
|
| [11] |
Okuyama Y, Fukui A, Enoki Y, et al. A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition[J]. Jpn J Clin Oncol, 2013, 43(5): 571-574. doi: 10.1093/jjco/hyt033
|
| [12] |
Usmani S, Pazooki M, Bilgrami SF. Small-cell carcinoma of the gallbladder: role of adjuvant chemotherapy[J]. J Gastrointest Cancer, 2010, 41(1): 84-87. doi: 10.1007/s12029-009-9122-7
|
| [13] |
Ueno M, Ikeda M, Morizane C, et al. Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase Ⅰ study[J]. Lancet Gastroenterol Hepatol, 2019, 4(8): 611-621. doi: 10.1016/S2468-1253(19)30086-X
|
| [14] |
Vinik A, Bang Y, Raoul J, et al. Patient-reported outcomes (PROs) in patients (pts) with pancreatic neuroendocrine tumors (NET) receiving sunitinib (SU) in a phase Ⅲ trial[J]. J Clin Oncol, 2010, 28(15_suppl): 4003. doi: 10.1200/jco.2010.28.15_suppl.4003
|
| [15] |
Elahi F, Ahmadzadeh A, Yadollahzaden M, et al. Neuroendocrine tumor of the gallbladder[J]. Arch Iran Med, 2013, 16(2): 123-125.
|
| [16] |
Shimono C, Suwa K, Sato M, et al. Large cell neuroendocrine carcinoma of the gallbladder: Long survival achieved by multimodal treatment[J]. Int J Clin Oncol, 2009, 14(4): 351-355. doi: 10.1007/s10147-008-0843-6
|
| 1. |
周宁，王虎明，张萱，李丽莉，徐杰，高玉骞. D-二聚体与淋巴细胞比值对B细胞淋巴瘤患者预后预测的临床价值研究. 标记免疫分析与临床. 2023(10): 1688-1694 .
|
Figures(4)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: